Yoga as effective as strength exercises for osteoarthritis pain relief

April 17, 2025 Yoga is as effective for addressing knee pain due to osteoarthritis as muscle-strengthening exercises, according to a new study. The randomized clinical trial has also found that yoga may improve health-related quality of life and reduce depression in people with knee osteoarthritis.

Read more in this article by Robbie Berman in Medical News Today.

Repurposing a blood pressure drug may prevent vision loss in inherited blinding diseases

April 15, 2025 New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa. No therapy exists for this rare inherited disease, which starts affecting vision from childhood.

Read more in this News Release from NIH.

Diabetes drugs like Ozempic or Jardiance may slash Alzheimer's risk

April 9, 2025 A new study investigates the relationship between specific diabetes drugs and dementia. They used data from more than 92,000 people with type 2 diabetes. The scientists found that two medications significantly reduce the risk of developing dementia in life.

Read more in this article by Tim Newman in Medical News Today.

Fact-Check: Did RFK Jr. Use Steroids to Build Muscle? Here's What We Know

April 3, 2025 Robert F. Kennedy Jr., now serving as Secretary of Health and Human Services under President Donald Trump, continues to face renewed scrutiny over his use of testosterone replacement therapy—an anabolic steroid—after posting a series of shirtless workout videos that went viral and reignited earlier claims he was using performance-enhancing drugs.

"The reason he looks like this is not because of the vitamins," body builder Greg Doucette said in the video. "It's not because he doesn't consume pesticides. It doesn't have anything to do with this. It's because he trains harder than last time, and he's on test, (also known as) steroids."

Read more in this article by Jenna deJong in Newsweek.

CDC Layoffs Deliver Devastating Blow to Respiratory Health

April 1, 2025 We are all deeply concerned about recent staff reductions at CDC, which put critical public health programs at risk. These cuts threaten essential services for millions of people with asthma and allergies, worsening health outcomes and limiting efforts to address environmental and occupational health risks. Nearly 28 million people in the United States have asthma and about 10 people still die every day from the disease.

Read more in this press release from the Asthma and Allergy Foundation of America.

A1C chart and understanding A1C levels

March 27, 2025 The A1C test measures a person’s average blood glucose or blood sugar levels over the past 3 months. An A1C reading of over 5.6% may be a cause for concern, but this will depend on various factors.

Read more in this article by Heather Grey in Medical News Today.

Scientists unveil how key protein malfunctions and leads to Parkinson's

March 20, 2025 The exact cause of Parkinson’s disease remains unknown; however, researchers know some genetic factors contribute to the condition, such as a mutation in the PINK1 gene. A new study for the first time explains what human PINK1 looks like and how it is activated. Researchers believe these findings may help one day lead to new treatment options for Parkinson’s disease.

Read more in this article by Corrie Pelc in Medical News Today.

NIH-funded study identifies potential new stroke treatment

March 17, 2025 In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The findings suggest that the treatment may work as an add-on therapy to standard stroke treatments in humans.

Courtesy of NIH

Read more in this media advisory from NIH.

Vitamin A can't prevent measles. Experts explain what this supplement actually does

March 14, 2025 In the past, severe vitamin A deficiency led to more severe outcomes with measles. Because of this, it is recommended that two doses of vitamin A be given to children (especially those under the age of 2 years old) with severe measles. However, experts caution that vitamin A provides no benefit as a preventive measure.

Courtesy of NIH

Read more in this article by Yasemin Nicola Sakay in Medical News Today.

Intermittent fasting may help prevent blood clots

March 6, 2025 Researchers, using 160 study participants, human blood samples, and mice, found that intermittent fasting appears to help stop platelet activation and clot formation. The results suggest that it does this by enhancing the gut microorganisms’ production of indole-3-propionic acid, which then affects clotting.

Read more in this article by Jessica Freeborn in Medical News Today.

Omalizumab treats multi-food allergy better than oral immunotherapy

March 3, 2025 A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small amounts of common food allergens. 

Courtesy of NIH

Read more in this news release from NIH.

GLP-1 could help reduce brain inflammation

February 23, 2025 According to the existing research, the “function of GLP-1 agonists is to lower serum glucose levels and thereby manage metabolism in affected patients.” GLP-1 drugs also improve blood flow to the heart and act directly on the hypothalamus to increase the sensation of being full after a meal. Besides these metabolic effects, GLP-1 drugs also appear to have an impact on brain health and mental health.

Read more in this article by Erika Watts in Medical News Today.

Health misinformation and disinformation: How to avoid it

February 21, 2025 In the age of viral content and fast and furious social media communication, disinformation and misinformation, including about health matters, are spreading more widely than ever. Why is this the case exactly, and how can we learn to spot inaccurate and even malicious health information? Why do we fall so easily for false health info, and how can we update our mistaken beliefs?

Read more in this article by Maria Cohut in Medical News Today.

Can drugs like Ozempic help with COPD?

February 17, 2025 A new study published in JAMA Internal Medicine reports that people who have type 2 diabetes and are treated with sodium-glucose cotransporter-2 inhibitors (SGLT-2is) or glucagon-like peptide-1 receptor agonists (GLP-1RAs) — like Ozempic and Wegovy — may be at a lower risk of moderate or severe COPD exacerbations, or symptom flare-ups, compared to those taking dipeptidyl peptidase 4 inhibitors (DPP-4is).

Read more in this article by Corrie Pelc in Medical News Today.

Are eggs good or bad for cholesterol? Outdated misconceptions seem to persist

February 14, 2025 A new study has found that misconceptions about eggs may still be keeping people from including them in their daily diets.

From Wikipedia

Read more in this article by Corrie Pelc in Medical News Today. (The research was funded by an unrestricted grant from the American Egg Board’s Egg Nutrition Center, but the authors declare no conflicts of interest.)

Daily omega-3 supplements and regular exercise may slow aging

February 7, 2025 A new study In Nature Aging suggests that omega-3 and vitamin D supplements, when combined with regular exercise, may help slow biological aging by several months over a 3-year period.

Read more in this article by Paul Ian Cross in Medical News Today.

Use of Body Armor by EMS Clinicians, Workplace Violence, and Racial and Ethnic Disparities in Care

January 29, 2025 Workplace violence is a significant occupational hazard, with data from the Bureau of Labor Statistics demonstrating the rate of workplace violence injuries among health care practitioners to be more than 3 times higher than the national average for all occupations in the US. This includes EMS personnel who are often exposed to workplace violence in the field and in the homes of patients, often with fewer resources and staff to mitigate violence.

Read more in this original investigation in JAMA Network Open.

Contact lenses used to slow nearsightedness in youth have a lasting effect

January 16, 2025 In a study funded by the National Institutes of Health, researchers found that children who wore special contact lenses to slow progression of nearsightedness, known as myopia, maintained the treatment benefit after they stopped wearing the contacts as older teens.

Courtesy of NIH.

Read more in this media advisory from NIH.

NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2

January 13, 2025 New findings from NIH suggest that infection with SARS-CoV-2 may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases. 

Read more in this media advisory from NIH.

NIH researchers discover novel class of anti-malaria antibodies

January 3, 2025 A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new prevention methods, according to a study from researchers at the National Institutes of Health published today in Science. 

 Red blood cells infected with malaria (orange cell). Courtesy of NIH.

Read more in this media advisory from NIH.

Aging may change some brain cells more than others

January 2, 2025 Based on new brain mapping research funded by the National Institutes of Health (NIH), scientists have discovered that not all cell types in the brain age in the same way. They found that some cells, such as a small group of hormone-controlling cells, may undergo more age-related changes in genetic activity than others. The results, published in Nature, support the idea that some cells are more sensitive to the aging process and aging brain disorders than others.

CDC.

Read more in this news release from NIH.

Aerobic Exercise and Weight Loss in Adults

December 26, 2024 In this meta-analysis of randomized clinical trials, engaging in 30 minutes of aerobic exercise per week was associated with modest reductions in body weight, waist circumference, and body fat measures among adults with overweight or obesity.

National Institutes of Health

Read more in this systematic review in JAMA Network Open. 

Reported use of most drugs among adolescents remained low in 2024

December 17, 2024 After declining significantly during the COVID-19 pandemic, substance use among adolescents has continued to hold steady at lowered levels for the fourth year in a row, according to the latest results from the Monitoring the Future Survey, which is funded by the National Institutes of Health. These recent data continue to document stable and declining trends in the use of most drugs among young people.

Read more in this news release from the National Institutes of Health.

Long-term exposure to air pollution linked to blood clots in veins that bring blood to the heart

December 12, 2024 A large study found that greater exposure to long-term air pollution was linked with increased risks for blood clots that can occur in deep veins, which, if untreated, can block blood flow and cause serious complications, even death.

Read more in this media advisory from the National Institutes of Health.

In five cancer types, prevention and screening have been major contributors to saving lives

December 5, 2024 Improvements in cancer prevention and screening have averted more deaths from five cancer types combined over the past 45 years than treatment advances, according to a modeling study led by researchers at the National Institutes of Health. 

From Cancer.gov

Read more in this news release from the National Cancer Institute.

NIH-led scientific team defines elements of brain-based visual impairment in children

November 19, 2024 Experts convened by the National Institutes of Health (NIH) have identified five elements of a brain-based condition that has emerged as a leading cause of vision impairment starting in childhood in the United States and other industrialized nations. Known as cerebral (or cortical) visual impairment (CVI), some estimates suggest that at least 3% of primary school children exhibit CVI-related visual problems, which vary, but may include difficulty visually searching for an object or person or understanding a scene involving complex motion. Their report, based on evidence and expert opinion, was published today in Ophthalmology.

Read more in this news release from NIH.

Researchers uncover new role of mutant proteins in some of the deadliest cancers

November 12, 2024 Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface. Mutant RAS, they found, helps to kick off a series of events involving the transport of specific nuclear proteins that lead to uncontrolled tumor growth, according to a study published Nov. 11, 2024, in Nature Cancer.

Read more in this news release from NIH.

Salivary Enzyme Behind Our Carb Cravings May Have Unexpectedly Ancient History

November 7, 2024 Digestion involves much more than just your stomach. The digestive process that fuels your body begins in your mouth each time you take a bite of food and chew. An enzyme in your saliva, called amylase, then starts to break down complex carbohydrates—or starches found in many fruits, vegetables, and grains—into simpler sugars to give you their sweet flavor followed by a burst of energy.

Read more in this article by  Dr. Monica M. Bertagnolli in NIH Director's Blog.

Why protective antibodies fade after COVID-19 vaccines

October 29, 2024 Researchers found that current COVID-19 vaccines fail to generate mature and durable antibody-producing cells in the bone marrow. The findings could help explain why protection tends to decline over time. Better understanding of long-term immune responses could lead to improved vaccines that provide enduring protection.

 From NIH

Read more in this news release from NIH Research Matters.

New course: Pennsylvania: Child Abuse, Recognition and Reporting for Mandated Reporters, 3 units (331)

October 20, 2024 This online course is for healthcare providers and other professionals in Pennsylvania who are mandated to report suspected child abuse. 

Click here to access PA Child Abuse, 3 units.

Alzheimer’s disease may damage the brain in two phases

October 15, 2024 Alzheimer’s disease may damage the brain in two distinct phases, based on new research funded by the National Institutes of Health (NIH) using sophisticated brain mapping tools. According to researchers who discovered this new view, the first, early phase happens slowly and silently — before people experience memory problems — harming just a few vulnerable cell types. In contrast, the second, late phase causes damage that is more widely destructive and coincides with the appearance of symptoms and the rapid accumulation of plaques, tangles, and other Alzheimer’s hallmarks.

Read more in this news release from NIH.

NIH launches large study to tackle type 2 diabetes in young people

October 9, 2024 In an effort to identify risk factors for youth-onset type 2 diabetes to improve prevention and treatment, the National Institutes of Health has launched a nationwide consortium to address the dramatic rise in youth diagnosed with type 2 diabetes over the past two decades, a trend that is expected to continue. 

Read more in this press release from NIH. 

After a rocky debut for new RSV tools, hopes are high as a new season approaches

October 4, 2024 RSV is a common virus that causes cold-like symptoms; it infects people at any age. But while most adults would probably write off an RSV infection as just a nasty cold, the illness triggered in older adults and babies is typically more severe. That is particularly true in young babies, whose lungs are still developing.

Read more in this article by Helen Branswell in STAT Health.

Millions of Americans want to quit smoking. Critics say drugmakers and the FDA are failing them

September 23, 2024 Of the roughly 15 million Americans who tried to quit smoking in 2022, 5 in 6 failed. It’s a jarring statistic — and an indictment of the treatment options for an addiction that kills 480,000 people in the U.S. each year.

The smoking-cessation drugs on the market don’t work well for the majority of people, and they come with side effects and reputations that keep some smokers from ever trying them. Despite this, there hasn’t been a new class of drug approved for the condition in nearly two decades. 

Read more in this article by Nicholas Florko in STAT Health.

Use of metformin in adults with diabetes linked to lower risk of long COVID

September 17, 2024 Large NIH-funded study supports previous studies showing potential benefit. Adults who use the prescription drug metformin to treat their type 2 diabetes have a lower risk of developing long COVID or dying after a COVID-19 infection than people with diabetes who take other anti-diabetes medications, according to a large study supported by the National Institutes of Health.

Read more in this news release from NIH.

Experimental blood test predicts risk for developing COPD, other severe respiratory diseases

September 10, 2024 A scientific team supported by the National Institutes of Health (NIH) has created a preclinical blood test to identify adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease (COPD). 

 Courtesy of NIH

Read more in this news release from NIH. 

Doctors use problematic race-based algorithms to guide care every day. Why are they so hard to change?

September 3, 2024 Pediatrician Alexandra Epee-Bounya had had enough. In her 20 years caring for children in Boston, she had seen hundreds of kids with suspected urinary tract infections. Each time, she’d turn to a calculator, used by all Boston Children’s Hospital clinicians, to judge the youngest children’s risk. Did the infant have a high fever? Add a point. Was she a girl? Add two points. 

As she went down the list, one of the factors tripped her up every time: Was the child Black? If not, add a point. The more points, the higher the risk of a UTI, which meant the child would get follow up testing. How could it be that the color of a child’s skin dictated their care? 

Read more in this article by Katie Palmer and Usha Lee McFarling in STAT.

Cannabis and hallucinogen use among adults remained at historic highs in 2023

August 29, 2024 Reports of vaping nicotine or vaping cannabis in the past year among adults 19 to 30 rose over five years, and both trends remained at record highs in 2023. 

Courtesy of NIH

Read more in this news release from NIH.

Self-adjusting brain pacemaker may help reduce Parkinson’s disease symptoms

August 20, 2024 A small feasibility study funded by the National Institutes of Health (NIH) found that an implanted device regulated by the body’s brain activity could provide continual and improved treatment for the symptoms of Parkinson’s disease (PD) in certain people with the disorder. 

Courtesy of NIH

Read more in this news release from NIH.

NIH launches program to advance research led by Native American communities on substance use and pain

August 15, 2024 Many Tribal Nations have developed and continue to develop innovative approaches and systems of care for community members with substance use and pain disorders. During NIH Tribal Consultations in 2018 and 2022, Tribal leaders categorized the opioid overdose crisis as one of their highest priority issues and called for research and support to respond. They shared that Native communities must lead the science and highlighted the need for research capacity building, useful real-time data, and approaches that rely on Indigenous Knowledge and community strengths to meet the needs of Native people.

Read more in this news release for NIH. 

Routine lab tests are not a reliable way to diagnose long COVID

August 12, 2024 NIH-supported study suggests novel biomarkers that distinguish the condition from other ailments are needed. A National Institutes of Health-supported study has found that routine lab tests may not be useful in making a long COVID diagnosis for people who have symptoms of the condition. The study, part of NIH’s Researching COVID to Enhance Recovery Initiative and published in the Annals of Internal Medicine, highlights how challenging it can be to identify and diagnose a novel illness such as long COVID.

Courtesy of NIH

Read more in this news release from NIH.

Medicaid vision coverage for adults varies widely by state

August 6, 2024 NIH-funded study finds lack of coverage, copays, restrictive policies barriers to vital eye care for adults. A study supported by the National Institutes of Health shows that 6.5 million Medicaid enrollees (12%) lived in states without coverage for routine adult eye exams; and 14.6 million (27%) resided in states without coverage for eyeglasses. The study based on 2022-23 coverage policies, published in Health Affairs, is among the first to provide a comprehensive, state-by-state analysis of adult Medicaid benefits for basic vision services in both fee-for-service and managed care.

Courtesy of NIH

Read more in this news release from NIH.

NIH researchers discover potential therapeutic target for degenerative eye disease

Study reveals cellular pathology of “dry” AMD.

July 26, 2024 Researchers from the National Institutes of Health (NIH) have discovered the source of dysfunction in the process whereby cells in the eye's retina remove waste.

Courtesy of NIH

A report by scientists at NIH and Johns Hopkins University, Baltimore, details how alterations in a factor called AKT2 affects the function of organelles called lysosomes and results in the production of deposits in the retina called drusen, a hallmark sign of dry age-related macular degeneration (AMD). According to the researchers, the findings suggest drusen formation is a downstream effect of AKT2-related lysosome dysfunction and points to a new target for therapeutic intervention.

Read more in this news release from NIH.